Demant Gross Profit 2012-2023 | WILYY
- Demant gross profit for the quarter ending December 31, 2023 was $M, a NAN% increase year-over-year.
- Demant gross profit for the twelve months ending December 31, 2023 was $0M, a NAN% increase year-over-year.
- Demant annual gross profit for 2023 was $2.402B, a 15.65% increase from 2022.
- Demant annual gross profit for 2022 was $2.077B, a 5.08% decline from 2021.
- Demant annual gross profit for 2021 was $2.188B, a 40.13% increase from 2020.
Demant Annual Gross Profit (Millions of US $) |
|
---|---|
2023 | $2,402 |
2022 | $2,077 |
2021 | $2,188 |
2020 | $1,562 |
2019 | $1,698 |
2018 | $1,708 |
2017 | $1,523 |
2016 | $1,342 |
2015 | $1,175 |
2014 | $1,666 |
2013 | $1,188 |
2012 | $1,059 |
2011 | $1,080 |
Demant Quarterly Gross Profit (Millions of US $) |
|
---|---|
2023-12-31 | |
2023-06-30 | |
2022-12-31 | |
2022-06-30 | |
2021-12-31 | |
2021-06-30 | |
2020-12-31 | |
2020-06-30 | |
2019-12-31 | |
2019-06-30 | |
2018-12-31 | |
2018-06-30 | |
2017-12-31 | |
2017-06-30 | |
2016-12-31 | |
2016-06-30 | |
2015-12-31 | |
2014-06-30 | |
2013-12-31 | |
2013-06-30 | |
2012-12-31 | |
2012-06-30 | |
2011-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $9.853B | $3.257B |
Demant A/S is engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The company's business area consists of Hearing Devices, Hearing Implants, Diagnostic Instruments and Personal Communication. Demant A/S, formerly known as William Demant Holding A/S, is based in Smorum, Denmark. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $185.786B | 24.39 |
Stryker (SYK) | United States | $124.672B | 30.91 |
Medtronic (MDT) | Ireland | $106.983B | 15.15 |
Boston Scientific (BSX) | United States | $99.792B | 33.18 |
EssilorLuxottica (ESLOY) | France | $98.590B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.472B | 0.00 |
Haleon (HLN) | United Kingdom | $38.173B | 29.86 |
ResMed (RMD) | United States | $26.527B | 26.52 |
Terumo (TRUMY) | Japan | $25.252B | 35.66 |
Zimmer Biomet Holdings (ZBH) | United States | $24.816B | 15.98 |
Baxter (BAX) | United States | $20.516B | 14.96 |
Koninklijke Philips (PHG) | Netherlands | $19.139B | 15.27 |
Insulet (PODD) | United States | $11.513B | 60.45 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.649B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.989B | 23.80 |
BellRing Brands (BRBR) | United States | $7.214B | 38.79 |
Lantheus Holdings (LNTH) | United States | $4.324B | 11.16 |
Haemonetics (HAE) | United States | $4.247B | 21.72 |
Perrigo (PRGO) | Ireland | $4.074B | 11.65 |
GN Store Nord (GNNDY) | Denmark | $3.937B | 25.50 |
Prestige Consumer Healthcare (PBH) | United States | $3.466B | 16.39 |
Envista Holdings (NVST) | United States | $3.456B | 13.14 |
QuidelOrtho (QDEL) | United States | $2.614B | 9.49 |
Neogen (NEOG) | United States | $2.552B | 24.54 |
Green Thumb Industries (GTBIF) | United States | $2.526B | 80.07 |
ICU Medical (ICUI) | United States | $2.348B | 17.52 |
TG Therapeutics (TGTX) | United States | $2.179B | 705.00 |
Owens & Minor (OMI) | United States | $1.856B | 17.82 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.853B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.698B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.652B | 0.00 |
National Vision Holdings (EYE) | United States | $1.444B | 44.98 |
InMode (INMD) | Israel | $1.439B | 7.45 |
LeMaitre Vascular (LMAT) | United States | $1.409B | 46.50 |
AdaptHealth (AHCO) | United States | $1.276B | 9.60 |
Warby Parker (WRBY) | United States | $1.218B | 0.00 |
AtriCure (ATRC) | United States | $1.099B | 0.00 |
MacroGenics (MGNX) | United States | $0.964B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.761B | 0.00 |
Canopy Growth (CGC) | Canada | $0.715B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.693B | 14.97 |
Cresco Labs (CRLBF) | United States | $0.684B | 0.00 |
Evolus (EOLS) | United States | $0.679B | 0.00 |
Quanterix (QTRX) | United States | $0.623B | 0.00 |
Valneva SE (VALN) | France | $0.552B | 0.00 |
Jin Medical (ZJYL) | China | $0.532B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.529B | 11.45 |
PetIQ (PETQ) | United States | $0.486B | 18.14 |
TerrAscend (TSNDF) | Canada | $0.475B | 0.00 |
ZimVie (ZIMV) | United States | $0.422B | 25.82 |
Biote (BTMD) | United States | $0.414B | 3.94 |
OraSure Technologies (OSUR) | United States | $0.409B | 6.77 |
Surmodics (SRDX) | United States | $0.361B | 39.06 |
Zynex (ZYXI) | United States | $0.358B | 41.26 |
Aurora Cannabis (ACB) | Canada | $0.343B | 0.00 |
Cerus (CERS) | United States | $0.306B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.304B | 30.15 |
Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.245B | 14.91 |
Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
Veru (VERU) | United States | $0.186B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.183B | 0.00 |
Omeros (OMER) | United States | $0.178B | 0.00 |
High Tide (HITI) | Canada | $0.171B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.160B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.156B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.133B | 66.92 |
FitLife Brands (FTLF) | United States | $0.129B | 20.77 |
Jushi Holdings (JUSHF) | United States | $0.127B | 0.00 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Cellectar Biosciences (CLRB) | United States | $0.103B | 0.00 |
Fonar (FONR) | United States | $0.103B | 8.80 |
MariMed (MRMD) | United States | $0.096B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.091B | 0.00 |
Chimerix (CMRX) | United States | $0.082B | 0.00 |
Brainsway (BWAY) | Israel | $0.079B | 0.00 |
Safety Shot (SHOT) | United States | $0.077B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.065B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Apyx Medical (APYX) | United States | $0.044B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
Bright Green (BGXX) | United States | $0.038B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 14.52 |
Modular Medical (MODD) | United States | $0.035B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
GlucoTrack (GCTK) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 72.73 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |